Abstract
Plant transformation technology plays an ever-increasing role in improving crop plant traits and addressing research questions. In recent years, a number of important patents on plant transgenic technologies have been published. These patents represent significant new progresses, many representing novel approaches in the field of plant transgenic technology. This review highlights selected as well as the most significant advancements made mostly within the past 2 years in plant transgenic research. These advancements include the improvements of plant transformation systems, development of new plant selectable markers, engineering for plant stress tolerance, production of vaccines in transgenic plants, etc. Of these, the engineering for plant stress tolerance accounts for a high percentage of the transgenic field of inventions. Some results are drastic and unexpected, having a great potential in their applications towards a wider range of plant species. This review also tries to avoid terms and languages pertaining to the patent and legal documents to ease readings.
Keywords: Agrobacterium, T-DNA, transformation, selectable marker, stress tolerance, transgenic plant, vaccine
Recent Patents on Biotechnology
Title: Recent Patents on Plant Transgenic Technology
Volume: 4 Issue: 2
Author(s): Xiaoyan Yin and Zhanyuan J. Zhang
Affiliation:
Keywords: Agrobacterium, T-DNA, transformation, selectable marker, stress tolerance, transgenic plant, vaccine
Abstract: Plant transformation technology plays an ever-increasing role in improving crop plant traits and addressing research questions. In recent years, a number of important patents on plant transgenic technologies have been published. These patents represent significant new progresses, many representing novel approaches in the field of plant transgenic technology. This review highlights selected as well as the most significant advancements made mostly within the past 2 years in plant transgenic research. These advancements include the improvements of plant transformation systems, development of new plant selectable markers, engineering for plant stress tolerance, production of vaccines in transgenic plants, etc. Of these, the engineering for plant stress tolerance accounts for a high percentage of the transgenic field of inventions. Some results are drastic and unexpected, having a great potential in their applications towards a wider range of plant species. This review also tries to avoid terms and languages pertaining to the patent and legal documents to ease readings.
Export Options
About this article
Cite this article as:
Yin Xiaoyan and J. Zhang Zhanyuan, Recent Patents on Plant Transgenic Technology, Recent Patents on Biotechnology 2010; 4 (2) . https://dx.doi.org/10.2174/187220810791110688
DOI https://dx.doi.org/10.2174/187220810791110688 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advances in Metagenomics: Innovations and Patentable Biotechnologies
Metagenomics has revolutionized biotechnology by enabling the comprehensive analysis of microbial communities in diverse environments. The application of metagenomic approaches has led to the discovery of novel genes, enzymes, bioactive compounds, and metabolic pathways with significant industrial, environmental, and medical applications. This Thematic Issue will focus on recent advancements in ...read more
AI-Driven Innovations in Medical Biotechnology: Transforming Healthcare with Machine Learning and Deep Learning Technologies
The integration of Artificial Intelligence (AI) and Machine Learning (ML) into medical biotechnology is significantly advancing healthcare technologies. These innovations are improving diagnostics, disease prevention, treatment personalization, and medical research. By harnessing vast datasets, AI and ML algorithms are enabling healthcare professionals to make more accurate predictions, optimize patient outcomes, ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Atorvastatin and Diabetic Vascular Complications
Current Pharmaceutical Design The Guinea Pig as an Animal Model for Asthma
Current Drug Targets Targeting Interleukin-1β for Pain
CNS & Neurological Disorders - Drug Targets Notch Inhibitors as a New Tool in the War on Cancer: A Pathway to Watch
Current Pharmaceutical Biotechnology T-type Ca Channel Blockers in Patients with Chronic Kidney Disease in Clinical Practice
Current Hypertension Reviews Natural and Synthetic Furanocoumarins as Treatment for Vitiligo and Psoriasis
Current Drug Therapy Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Current Pharmaceutical Design A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia
Current Molecular Pharmacology Pleiotropic Effects of ARB on Dyslipidemia
Current Vascular Pharmacology Inflammation: Beneficial or Detrimental After Spinal Cord Injury?
Recent Patents on CNS Drug Discovery (Discontinued) P2Y Receptor Activation Affects the Proliferation and Differentiation of Glial and Neuronal Cells: A Focus on Rat C6 Glioma Cells
Current Neuropharmacology Critical Role of IL-8 Targeting in Gliomas
Current Medicinal Chemistry Bone Marrow Stem Cell Therapy for Myocardial Angiogenesis
Current Vascular Pharmacology Imaging Stem Cell Therapy for the Treatment of Peripheral Arterial Disease
Current Vascular Pharmacology The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19
Current Medicinal Chemistry Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis
Current Pharmaceutical Design New Prospectives in the Delivery of Galantamine for Elderly Patients Using the IntelliDrug Intraoral Device: In Vivo Animal Studies
Current Pharmaceutical Design Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets The Mast Cell Pathway to Inflammation and Homeostasis: Pharmacolo- gical Insights
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pleiotropic Effects of Drugs Inhibiting the Renin-Angiotensin-Aldosterone System
Current Pharmaceutical Design